Clinical Trial Update: Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immune checkpoint inhibitors with or without propranolol hydrochloride in urothelial carcinoma; the study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma
• Urothelial Carcinoma of the Bladder
• Urothelial Carcinoma of the Renal Pelvis
• Urothelial Carcinoma of the Ureter
• Urothelial Carcinoma of the Urethra

Drugs mentioned

• Immune checkpoint inhibitors (immune checkpoint inhibitor)
• Propranolol Hydrochloride (propranolol hydrochloride)

Snippet

Sponsor: Emory University | Conditions: Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING